A caspase-resistant form of Bcl-X(L), but not wild type Bcl-X(L), promotes clonogenic survival after ionizing radiation.
A caspase-resistant form of Bcl-X(L), but not wild type Bcl-X(L), promotes clonogenic survival after ionizing radiation.
复制标题
半胱天冬酶抗性形式的 Bcl-X(L)(而非野生型 Bcl-X(L))可促进电离辐射后克隆形成的存活。
DOI:
10.1038/sj.neo.7900013
复制
发表时间:
1999
期刊:
影响因子:
--
通讯作者:
Chinnaiyan,A
中科院分区:
文献类型:
--
作者:
Rehemtulla,A;Hamilton,AC;Taneja,N;Fridman,J;Juan,TS;Maybaum,J;Chinnaiyan,A
Bcl-2 and Bcl-XLbelong to a family of proteins overexpressed in a variety of human cancers which inhibit apoptosis in response to a number of stimuli including chemotherapeutic agents and ionizing radiation. To better understand the role of these polypeptides in modulating the response of cancer cells to ionizing radiation we used cell lines that were engineered to overexpress the two polypeptides. Although Bcl-2 and Bcl-XLoverexpression resulted in inhibition of radiation induced apoptosis, it did not result in enhanced clonogenic survival. Consistent with this was the observation that Bcl-2 and Bcl-XLprotected cells from DNA fragmentation, loss of mitochondrial membrane potential, and caspase activation for up to 72 hours after irradiation. Beyond 72 hours, there was a rapid loss in the ability of Bcl-2 and Bcl-XLto inhibit these markers of apoptosis. When Bcl-XLwas analyzed at 72 hours after irradiation and beyond, a rapid accumulation of a 16-kDa form of Bcl-XLwas observed. To test the hypothesis that cleavage of the 29-kDa form of Bcl-XLby caspases to a 16-kDa polypeptide results in its inability to inhibit apoptosis beyond 72 hours, we constructed a cell line that overexpressed a caspase-resistant form of Bcl-XL(Bcl-XL-Δloop). Cells overexpressing Bcl-XL-Δloop were resistant to apoptosis beyond 72 hours after irradiation and did not contain the 16-kDa form at these time points. In addition, Bcl-XL-Δloop overexpression resulted in enhanced clonogenic survival compared with control or Bcl-XLoverexpressing cells. These results provide a molecular basis for the observation that expression of Bcl-2 or Bcl-XLis not a prognostic marker of tumor response to cancer therapy.
登录
查看更多内容
影响因子:
11.2
作者:
Richard B. Lock;L. Stribinskiene
通讯作者:
Richard B. Lock;L. Stribinskiene
DOI:
--
发表时间:
1995
期刊:
Cancer research.
影响因子:
--
作者:
Yin,DX;Schimke,RT
通讯作者:
Schimke,RT
影响因子:
8
作者:
A. Milner;R. Grand;A. Vaughan;R. Armitage;C. Gregory
通讯作者:
C. Gregory
影响因子:
8.8
作者:
Piris, M A;Pezzella, F;Martinez-Montero, J C;Orradre, J L;Villuendas, R;Sanchez-Beato, M;Cuena, R;Cruz, M A;Martinez, B;Pezella F [corrected to Pezzella, F ]
通讯作者:
Pezella F [corrected to Pezzella, F ]
影响因子:
8.8
作者:
M. Egan;J. Crocker
通讯作者:
J. Crocker